Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-19-224465
Filing Date
2019-08-19
Accepted
2019-08-19 16:05:10
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G d651168dsc13g.htm SC 13G 40036
  Complete submission text file 0001193125-19-224465.txt   41493
Mailing Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018
Business Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018 (646) 350-0702
Akari Therapeutics Plc (Subject) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: SC 13G | Act: 34 | File No.: 005-87614 | Film No.: 191036477
SIC: 2834 Pharmaceutical Preparations

Mailing Address XYMAX KAMIYACHO BUILDING 8/F, 5-12-13 TO MINATO-KU, TOKYO M0 105-0001
Business Address
Shigeta Yasumitsu (Filed by) CIK: 0001785722 (see all company filings)

Type: SC 13G